Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IDEAYA Biosciences Q3 EPS $1.33 Beats $(0.47) Estimate, Sales $207.834M Beat $5.975M Estimate

Author: Benzinga Newsdesk | November 04, 2025 06:29am
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $(0.47) by 380.59 percent. This is a 321.67 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $207.834 million which beat the analyst consensus estimate of $5.975 million by 3.38K percent.

Posted In: IDYA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist